Heron Therapeutics HRTX
NASDAQ HRTX
$0.36 -0.01 (-3.96%)
At close: Nov 11, 2026 · 4:00 PM EST

Heron Therapeutics (HRTX) Other financing activities (as filed) (2009 - 2026)

Updated

Heron Therapeutics (HRTX) reported Other financing activities of -$125 million for Q4 2025.

Analysis

Heron Therapeutics (HRTX) Other financing activities (as filed) (2009 - 2026) Analysis & Trends

For FY2025, Heron Therapeutics posted Other financing activities of $25 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Heron Therapeutics 70.40 Mn -87.13 Mn 26.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -4.40 Mn
Jun 30, 2026 3.00 Mn
Dec 31, 2025 -23.47 Mn
Mar 31, 2009 -3,000.00
API Access

Heron Therapeutics Other financing activities (as filed) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=HRTX&period=max&api_key=YOUR_API_KEY